↓ Skip to main content

Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants

Overview of attention for article published in Frontiers in oncology, July 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants
Published in
Frontiers in oncology, July 2022
DOI 10.3389/fonc.2022.932957
Pubmed ID
Authors

Ana Carolina Leite Vieira Costa Gifoni, Markus Andret Cavalcante Gifoni, Camila Martins Wotroba, Edenir Inez Palmero, Eduardo Leite Vieira Costa, Wellington dos Santos, Maria Isabel Achatz

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 10%
Student > Doctoral Student 2 10%
Lecturer > Senior Lecturer 1 5%
Other 1 5%
Student > Bachelor 1 5%
Other 1 5%
Unknown 12 60%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 15%
Medicine and Dentistry 3 15%
Mathematics 1 5%
Engineering 1 5%
Unknown 12 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2022.
All research outputs
#15,108,411
of 26,169,168 outputs
Outputs from Frontiers in oncology
#4,006
of 22,913 outputs
Outputs of similar age
#181,533
of 438,201 outputs
Outputs of similar age from Frontiers in oncology
#266
of 1,770 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 1,770 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.